The current lack of harmonisation of malaria vaccine assay conduct coupled with the lack of an enabling environment for comparing research results leads to scepticism about the comparability of assay results. Assay harmonisation is a central priority to enable rational malaria vaccine design and for decision-making in vaccine development.

The overall goal of this three year project is to develop harmonised assays to facilitate comparison of results and improve decision making on vaccine construct development, product characterisation, down selection of candidates and/or formulation, and clinical development plans.

The project involves thirteen partner institutions and is  funded by the European Commission's Framework Program 7 (FP7) as Coordination and Support Action, project number: 223126, with €1 000 000 and by additional complementary contributions from the PATH Malaria Vaccine Initiative and the Centers for Disease Control and Prevention. 

The official starting date of the project is 1st April  2009.